Working at iTeos

ABOUT ITEOS THERAPEUTICS

iTeos Therapeutics is a publicly-held (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies. 

Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UCLouvain) in 2011.

In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO raising over $200million of  proceeds.

This additional capital will allow us to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage its fantastic science to improve the lives of cancer patients.

The innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways. EOS-850, is designed as a highly selective small molecule antagonist of the adenosine A2a receptor, a key driver of immunosuppression in the tumor microenvironment across a broad range of tumors. EOS-850 is being investigated in an open-label Phase 1/2a clinical trial in adult patients with advanced solid tumors. 

The innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways. EOS-850, is designed as a highly selective small molecule antagonist of the adenosine A2a receptor, a key driver of immunosuppression in the tumor microenvironment across a broad range of tumors. EOS-850 is being investigated in an open-label Phase 1/2a clinical trial in adult patients with advanced solid tumors.

The lead antibody product candidate, EOS-448, is an antagonist of TIGIT, also designed to engage the Fc gamma receptor (FcγR). An open-label Phase 1/2a clinical trial of EOS-448 is currently ongoing in adult patients with advanced solid tumors.

For more information, please visit www.iteostherapeutics.com.

iTeos Therapeutics has the ambition to become a world-class actor in the sector. To carry on its growth and reinforce its team, iTeos Therapeutics is offering a full time position as Research Technician – In Vivo Pharmacology.

KEYS RESPONSIBILITIES

As a Research Technician, you perform in vivo assays to discover and to validate small molecules and biologics for the development of innovative cancer immunotherapies. Your main responsibilities are as follows :

• Perform experimental in vivo models of cancer, including compound dosage and endpoint assessment, according to Standard Operating Procedures.
• Perform pharmacokinetic and pharmacodynamics studies.
• Systematically compile data and report in Excel and in Prism files.
• Collaborate with other project stakeholders and discuss assays results with them.

This function requires occasional presence on Saturdays or Sundays (more or less once a month). The function may from time to time require starting work before 8am or ending the day between 5-7pm.  

PROFILE

• Bachelor in Life Sciences, Pharmacology, Biochemistry or closely related field.
• FELASA B/C certified.
• Experience in in vivo studies is a must. 
• Previous experience in Culture of cell lines for in-vivo studies and/or standard lab techniques (ELISA, qPCR, flow cytometry, etc.) is a plus.
• Previous experience in the biotech/pharma industry or in a similar academic position is an advantage.
• Knowledge of Microsoft Office. Knowledge of Prism is a plus.
• Good communication skills in French and English. 
• Rigorous, detail-oriented, organized, autonomous, committed and flexible.
• Strong team spirit and excellent interpersonal skills.

OFFER

• A stimulating scientific position within a high-potential innovative biotech company. 
• The opportunity to work in a science-driven, dynamic, human‐sized, respectful and professional environment. 
• A challenging scientific and business growth in which you get to bring your knowledge and skills.
• A permanent contract and an attractive salary package in line with the position responsibilities and your experience.

RECRUITMENT PROCESS

Please send your CV together with an adapted cover letter to the following address : jobs@iteostherapeutics.com. Please, mention the reference RT in the mail object. Your application and related information will remain strictly confidential.

For our recruitments in Belgium, we closely collaborate with a Recruitment & Selection company, PaHRtners. Your application will be automatically forwarded to them. We, together with PaHRtners, will keep all your data confidential (GDPR compliant approach).